Biocon Limited (BIOCON.BO)
INR 348.0
(0.01%)
INR 348.0
(0.01%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 162.76 Billion INR | -9.67% |
| 2022 | 180.18 Billion INR | 250.11% |
| 2021 | 51.46 Billion INR | 14.85% |
| 2020 | 44.81 Billion INR | 65.03% |
| 2019 | 27.15 Billion INR | 12.06% |
| 2018 | 24.23 Billion INR | 7.02% |
| 2017 | 22.64 Billion INR | -1.67% |
| 2016 | 23.02 Billion INR | -7.07% |
| 2015 | 24.77 Billion INR | 122.28% |
| 2014 | 11.14 Billion INR | 32.03% |
| 2013 | 8.44 Billion INR | 259.43% |
| 2012 | 2.34 Billion INR | 4.21% |
| 2011 | 2.25 Billion INR | -18.24% |
| 2010 | 2.75 Billion INR | -46.32% |
| 2009 | 5.13 Billion INR | -3.94% |
| 2008 | 5.34 Billion INR | 105.21% |
| 2007 | 2.6 Billion INR | 35.14% |
| 2006 | 1.92 Billion INR | 80.18% |
| 2005 | 1.07 Billion INR | 38.89% |
| 2004 | 770.45 Million INR | 17.54% |
| 2003 | 655.5 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 161.49 Billion INR | 2.34% |
| 2024 Q1 | 163.87 Billion INR | 0.68% |
| 2023 Q2 | 182.52 Billion INR | 4.46% |
| 2023 Q1 | 174.73 Billion INR | -3.03% |
| 2023 FY | 162.76 Billion INR | -9.67% |
| 2023 Q4 | 162.76 Billion INR | -1.85% |
| 2023 Q3 | 165.83 Billion INR | -9.15% |
| 2022 Q3 | 198.96 Billion INR | 239.56% |
| 2022 Q2 | 58.59 Billion INR | 5.23% |
| 2022 FY | 180.18 Billion INR | 250.11% |
| 2022 Q1 | 55.68 Billion INR | 8.19% |
| 2022 Q4 | 180.18 Billion INR | -9.44% |
| 2021 Q1 | 36.29 Billion INR | -19.02% |
| 2021 FY | 51.46 Billion INR | 14.85% |
| 2021 Q2 | 47.43 Billion INR | 30.7% |
| 2021 Q3 | 50.01 Billion INR | 5.44% |
| 2021 Q4 | 51.46 Billion INR | 2.91% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 26.87 Billion INR | 0.0% |
| 2020 Q4 | 44.81 Billion INR | 0.0% |
| 2020 FY | 44.81 Billion INR | 65.03% |
| 2019 FY | 27.15 Billion INR | 12.06% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 22.33 Billion INR | 0.0% |
| 2019 Q4 | 27.15 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 24.23 Billion INR | 21.21% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 21.16 Billion INR | 0.0% |
| 2018 Q3 | 19.99 Billion INR | -5.56% |
| 2018 FY | 24.23 Billion INR | 7.02% |
| 2017 Q1 | 22.9 Billion INR | -0.53% |
| 2017 Q4 | 22.64 Billion INR | 6.7% |
| 2017 Q3 | 21.21 Billion INR | -6.39% |
| 2017 Q2 | 22.66 Billion INR | -1.03% |
| 2017 FY | 22.64 Billion INR | -1.67% |
| 2016 Q2 | 24.44 Billion INR | 0.0% |
| 2016 FY | 23.02 Billion INR | -7.07% |
| 2016 Q3 | 25.45 Billion INR | 4.12% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 23.02 Billion INR | -9.53% |
| 2015 Q1 | 10.2 Billion INR | -8.5% |
| 2015 Q3 | 11.97 Billion INR | 0.26% |
| 2015 Q4 | 24.77 Billion INR | 106.99% |
| 2015 FY | 24.77 Billion INR | 122.28% |
| 2015 Q2 | 11.93 Billion INR | 17.05% |
| 2014 Q3 | 11.66 Billion INR | -1.43% |
| 2014 FY | 11.14 Billion INR | 32.03% |
| 2014 Q2 | 11.82 Billion INR | 27.06% |
| 2014 Q4 | 11.14 Billion INR | -4.4% |
| 2014 Q1 | 9.31 Billion INR | 10.27% |
| 2013 Q1 | 3.74 Billion INR | 59.22% |
| 2013 Q2 | 4.04 Billion INR | 8.15% |
| 2013 FY | 8.44 Billion INR | 259.43% |
| 2013 Q3 | 5.37 Billion INR | 32.77% |
| 2013 Q4 | 8.44 Billion INR | 57.23% |
| 2012 FY | 2.34 Billion INR | 4.21% |
| 2012 Q3 | 2.57 Billion INR | 0.0% |
| 2012 Q4 | 2.34 Billion INR | -8.6% |
| 2011 FY | 2.25 Billion INR | -18.24% |
| 2011 Q4 | 2.25 Billion INR | 0.0% |
| 2010 FY | 2.75 Billion INR | -46.32% |
| 2009 FY | 5.13 Billion INR | -3.94% |
| 2008 FY | 5.34 Billion INR | 105.21% |
| 2007 FY | 2.6 Billion INR | 35.14% |
| 2006 FY | 1.92 Billion INR | 80.18% |
| 2005 FY | 1.07 Billion INR | 38.89% |
| 2004 FY | 770.45 Million INR | 17.54% |
| 2003 FY | 655.5 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | -11899.121% |
| Blue Jet Healthcare Limited | 16.12 Million INR | -1008994.917% |
| Concord Biotech Limited | 97.37 Million INR | -167053.097% |
| Dishman Carbogen Amcis Limited | 23.12 Billion INR | -603.827% |
| FERMENTA BIOTECH LIMITED | 1.32 Billion INR | -12205.579% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 586.5 Million INR | -27652.212% |
| Panacea Biotec Limited | 209.9 Million INR | -77445.021% |
| SAMSRITA LABS LIMITED | 22.03 Million INR | -738675.418% |
| Servoteach Industries Limited | 5059.00 INR | -3217374875.292% |
| SMS Lifesciences India Limited | 1 Billion INR | -16059.736% |
| Supriya Lifescience Limited | 54.88 Million INR | -296487.099% |
| Syngene International Limited | 5.55 Billion INR | -2831.682% |
| TAKE Solutions Limited | 370.85 Million INR | -43790.252% |
| Titan Biotech Limited | 83.02 Million INR | -195936.325% |
| Transgene Biotek Limited | 140.01 Million INR | -116153.839% |
| Vanta Bioscience Limited | 609.53 Million INR | -26603.427% |